Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo

Oncotarget

Volumn 6, Issue 12, 2015, Pages 9951-9958

  Zhanfeng, Niu ^a,b   Yanhui, Li ^a   Zhou, Fei ^b   Shaocai, Hao ^a   Guangxing, Li ^a   Hechun, Xia ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Per1; Per2; Radiotherapeutic sensitivity

Indexed keywords

MESSENGER RNA; PER1 PROTEIN; PER2 PROTEIN; CIRCADIAN RHYTHM SIGNALING PROTEIN; PER1 PROTEIN, RAT; PER2 PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL PROLIFERATION; CIRCADIAN RHYTHM; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GLIOMA; MALE; MOUSE; NONHUMAN; PER1 GENE; PER2 GENE; PROTEIN EXPRESSION; RADIOSENSITIVITY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUNEL ASSAY; ANIMAL; BIOSYNTHESIS; BRAIN NEOPLASMS; GENETICS; METABOLISM; PARASITOLOGY; PATHOLOGY; RADIATION TOLERANCE; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN NEOPLASMS; CIRCADIAN RHYTHM; GLIOMA; MALE; PERIOD CIRCADIAN PROTEINS; RADIATION TOLERANCE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 84929587237     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3179     Document Type: Article

References (43)

1. You SJ, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005; 91:47-60.
2. Wood PA, Du-Quiton J, You S, Hrushesky WJ. Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther. 2006; 5:2023-33.
3. Hori K, Zhang QH, Li HC, Saito S, Sato Y. Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow. Int J Cancer. 1996; 65:360-4.
4. Efficace F, Innominato PF, Bjarnason G, Coens C, Humblet Y, Tumolo S, Genet D, Tampellini M, Bottomley A, Garufi C, Focan C, Giacchetti S, Lévi F. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the chronotherapy group of the European Organisation for Research and Treatment of Cancer. J Clin Oncol. 2008; 26:2020-26.
5. Eriguchi M, Levi F, Hisa T, Yanagie H, Nonaka Y, Takeda Y. Chronotherapy for cancer. Biomed Pharmacother. 2003; 57:92-95.
6. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003; 302:255-9.
7. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002; 111:41-50.
8. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006; 22:375-82.
9. Sun CM, Huang SF, Zeng JM, Liu DB, Xiao Q, Tian WJ, Zhu XD, Huang ZG, Feng WL. Per2 inhibits k562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction. Pathol Oncol Res. 2010; 16:403-11.
10. Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 2003; 3:350-61.
11. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 2006; 97:589-96.
12. Watanabe K, Sakamoto M, Somiya M, Amin MR, Kamitani H, Watanabe T. Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region. Neurol Res. 2002; 24:485-90.
13. Shinohara C, Gobbel GT, Lamborn KR, Tada E, Fike JR. Apoptosis in the subependyma of young adult rats after single and fractionated doses of X-rays. Cancer Res. 1997; 57:2694-702.
14. Verheyde J, de Saint-Georges L, Leyns L, Benotmane MA. The role of Trp53 in the transcriptional response to ionizing radiation in the developing brain. DNA Res. 2006; 13:65-75.
15. Xia HC, Niu ZF, Ma H, Cao SZ, Hao SC, Liu ZT, Wang F. Deregulated expression of the Per1 and Per2 in human gliomas. Can J Neurol Sci. 2010; 37:365-70.
16. Haus E. Chronobiology of the mammalian response to ionizing radiation. Potential applications in oncology. Chronobiol Int. 2002; 19:77-100.
17. Paez PM, Spreuer V, Handley V, Feng JM, Campagnoni C, Campagnoni AT. Increased expression of golli myelin basic proteins enhances calcium influx into oligodendroglial cells. J Neurosci. 2007; 27:12690-9.
18. Nakanishi M. Cell cycle checkpoints and cancer. Tanpakushitsu Kakusan Koso. 2009; 54:556-60.
19. Sancar A, Lindsey-Boltz LA, Ünsal-Kaçmaz K. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 2004; 73:39-85.
20. Duffield GE, Best JD, Meurers BH, Bittner A, Loros JJ, Dunlap JC. Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr Biol. 2002; 12:551-7.
21. Zhang J, Chen X. The p53 family: prospect for cancer gene therapy. Cancer Biol Ther. 2007; 6:116-8.
22. Stark GR, Taylor WR. Control of the G2/M transition. Mol Biotechnol. 2006; 32:227-48.
23. Rong Hu, Andrew E. Aplin. Skp2 regulates G2/M progression in a p53-dependent manner. Mol Biol Cell. 2008; 19:4602-10.
24. Shih RS, Wong SH, Schoene NW, Zhang JJ, Lei KY. Enhanced Gadd45 expression and delayed G2/M progression are p53-dependent in zinc-supplemented human bronchial epithelial cells. Exp Biol Med (Maywood). 2010; 235:932-40.
25. Cao Q, Gery S, Dashti A, Yin D, Zhou Y, Gu J, Koeffler HP. A role for the clock gene per1 in prostate cancer. Cancer Res. 2009; 69:7619-25.
26. Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol. 2005; 6:635-45.
27. Koh CM, Iwata T, Zheng Q, Bethel C, Yegnasubramanian S, De Marzo AM. Myc enforces overexpression of EZH2 in early prostatic neoplasia via transcriptional and posttranscriptional mechanisms. Oncotarget. 2011; 2:669-83.
28. Filipski E, Innominato PF, Wu M, Li XM, Iacobelli S, Xian LJ, Lévi F. Effects of light and food schedules on liver and tumor molecular clocks in mice. J Natl Cancer Inst. 2005; 97:507-17.
29. Ho JS, Ma W, Mao DY, et al. p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol. 2005; 25:7423-31.
30. Seoane J, Le H-V, Massagué J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 2002; 419:729-34.
31. Gery S, Komatsu N, Kawamata N, Miller CW, Desmond J, Virk RK, Marchevsky A, Mckenna R, Taguchi H, Koeffler HP. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin Cancer Res. 2007; 13:1399-404.
32. Wilson GD. Radiation and the cell cycle, revisited. Cancer Metastasis Rev. 2004; 23:209-25.
33. Tenzer A, Pruschy M. Potentiation of DNA-damageinduced cytotoxicity by G2 checkpoint abrogators. Curr Med Chem Anticancer Agents. 2003; 3:35-46.
34. Park JS, Jun HJ, Cho MJ, et al. Radiosensitivity enhancement by combined treatment of celecoxib and gefitinib on human lung cancer cells. Clin Cancer Res. 2006; 12:4989-99.
35. Turner J, Koumenis C, Kute TE, Planalp RP, Brechbiel MW, Beardsley D, Cody B, Brown KD, Torti FM, Torti SV. Tachpyridine, a metal chelator, induces G2 cell-cycle arrest, activates checkpoint kinases, and sensitizes cells to ionizing radiation. Blood. 2005; 106:3191-9.
36. Khapre RV, Patel SA, Kondratova AA, Chaudhary A, Velingkaar N, Antoch MP, Kondratov RV. Metabolic clock generates nutrient anticipation rhythms in mTOR signaling. Aging (Albany NY). 2014; 6:675-89.
37. Blagosklonny MV. Calorie restriction: decelerating mTORdriven aging from cells to organisms (including humans). Cell Cycle. 2010; 9:683-8.
38. Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD. Fasting and cancer treatment in humans:a case series report. Aging (Albany NY). 2009; 1:988-1007.
39. Khapre RV, Kondratova AA, Patel S, Dubrovsky Y, Wrobel M, Antoch MP, Kondratov RV. BMAL1-dependent regulation of the mTOR signaling pathway delays aging. Aging (Albany NY). 2014; 6:48-57.
40. Sahar S, Nin V, Barbosa MT, Chini EN, Sassone-Corsi P. Altered behavioral and metabolic circadian rhythms in mice with disrupted NAD+ oscillation. Aging (Albany NY). 2011; 3:794-802.
41. Brown SA, Schmitt K, Eckert A. Aging and circadian disruption:causes and effects. Aging (Albany NY). 2011; 3:813-7.
42. Yu EA, Weaver DR. Disrupting the circadian clock: genespecific effects on aging, cancer, and other phenotypes. Aging (Albany NY). 2011; 3:479-93.
43. Siffroi-Fernandez S, Dulong S, Li XM, Filipski E, Gréchez-Cassiau A, Peteri-Brünback B, Meijer L, Lévi F, Teboul M, Delaunay F. Functional genomics identify Birc5/survivin as a candidate gene involved in the chronotoxicity of cyclin-dependent kinase inhibitors. Cell Cycle. 2014; 13:984-91.